BlackRock’s Mural Oncology MURA Stock Holding History

BlackRock’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-287,580	Closed	-$595K	–	5604
2025 Q3	$595K	Buy	287,580 +1,179	+0.4%	+$2.53K	﹤0.01%	4417
2025 Q2	$707K	Sell	286,401 -56,393	-16%	-$133K	﹤0.01%	4363
2025 Q1	$432K	Sell	342,794 -783	-0.2%	-$2.85K	﹤0.01%	4434
2024 Q4	$1.11M	Sell	343,577 -2,577	-0.7%	-$9.09K	﹤0.01%	4198
2024 Q3	$1.08M	Buy	346,154 +3,529	+1%	+$11.5K	﹤0.01%	4155
2024 Q2	$1.08M	Sell	342,625 -741,328	-68%	-$2.73M	﹤0.01%	4161
2024 Q1	$5.3M	Sell	1,083,953 -89,054	-8%	-$432K	﹤0.01%	3650
2023 Q4	$6.94M	Buy	+1,173,007	New	+$4.72M	﹤0.01%	3559

BlackRock's MURA Position: Q4 2025 in Review

BlackRock sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 287,580 shares — an estimated $595K sold.

BlackRock first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $6.94M in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

BlackRock reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
BlackRock sold 287,580 Mural Oncology shares in Q4 2025, an estimated $595K.
BlackRock first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
BlackRock's Mural Oncology position peaked at $6.94M in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.